Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06018753 · ClinicalTrials.gov registry record
Umbrella Study for Analysis of Data Related to Patients With Cancer
A clinical trial of Cancer, sponsored by Tempus AI.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 10
- Study locations
NCT06018753 is a study of Cancer that is actively recruiting participants, run by Tempus AI. The registered enrollment target is 10,000 participants, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher). The trial reports 10 study locations across 9 states.
The verdict
NCT06018753, a study of Cancer, is actively recruiting participants, sponsored by Tempus AI.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study is a multisite, minimal risk, non-interventional study using patient electronic health record data collected as part of standard of care to answer cohort-based research questions and create robust real-world data sets.
Conditions Studied
Study Locations (10)
Illinois
- Illinois Cancer Care - Peoria
- Northwest Oncology and Hematology - Rolling Meadows
California
- Memorial Health Services - Fountain Valley
Florida
- Cancer Specialists of Northern Florida - Jacksonville
Hawaii
- Hawaii Cancer Care - Honolulu
Indiana
- Community Health Network - Indianapolis
Massachusetts
- Southcoast Centers for Cancer Care - Fairhaven
North Dakota
- Sanford Fargo - Fargo
Ohio
- Taylor Cancer Research Center - Maumee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2023-12-06 |
| Est. Completion | 2028-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06018753
The ClinicalTrials.gov registry entry for NCT06018753 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher). The listed sponsor is Tempus AI, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06018753 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Illinois, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06018753 about?
NCT06018753 is a clinical study titled "Umbrella Study for Analysis of Data Related to Patients With Cancer". This study is a multisite, minimal risk, non-interventional study using patient electronic health record data collected as part of standard of care to answer cohort-based research questions and create robust real-world data sets.
What is the current status of trial NCT06018753?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2023-12-06. Estimated completion is 2028-12-01.
What conditions does trial NCT06018753 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT06018753?
This trial is sponsored by Tempus AI, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06018753 being conducted?
This trial has 10 study locations across California, Florida, Hawaii, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.